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IMPORTANCE Suicide is a leading cause of deaths in the United States. Although the
emergency department (ED) is an opportune setting for initiating suicide prevention efforts,
ED-initiated suicide prevention interventions remain underdeveloped.
OBJECTIVE To determine whether an ED-initiated intervention reduces subsequent suicidal
behavior.
DESIGN, SETTING, AND PARTICIPANTS This multicenter study of 8 EDs in the United States
enrolled adults with a recent suicide attempt or ideation and was composed of 3 sequential
phases: (1) a treatment as usual (TAU) phase from August 2010 to December 2011, (2) a
universal screening (screening) phase from September 2011 to December 2012, and (3) a
universal screening plus intervention (intervention) phase from July 2012 to November 2013.
INTERVENTIONS Screening consisted of universal suicide risk screening. The intervention
phase consisted of universal screening plus an intervention, which included secondary suicide
risk screening by the ED physician, discharge resources, and post-ED telephone calls focused
on reducing suicide risk.
MAIN OUTCOMES ANDMEASURES The primary outcomewas suicide attempts (nonfatal and
fatal) over the 52-week follow-up period. The proportion and total number of attempts were
analyzed.
RESULTS A total of 1376 participants were recruited, including 769 females (55.9%) with a
median (interquartile range) age of 37 (26-47) years. A total of 288 participants (20.9%)
made at least 1 suicide attempt, and there were 548 total suicide attempts among
participants. There were no significant differences in risk reduction between the TAU and
screening phases (23% vs 22%, respectively). However, compared with the TAU phase,
patients in the intervention phase showed a 5% absolute reduction in suicide attempt risk
(23% vs 18%), with a relative risk reduction of 20%. Participants in the intervention phase
had 30% fewer total suicide attempts than participants in the TAU phase. Negative binomial
regression analysis indicated that the participants in the intervention phase had significantly
fewer total suicide attempts than participants in the TAU phase (incidence rate ratio, 0.72;
95% CI, 0.52-1.00; P = .05) but no differences between the TAU and screening phases
(incidence rate ratio, 1.00; 95% CI, 0.71-1.41; P = .99).
CONCLUSIONS AND RELEVANCE Among at-risk patients in the ED, a combination of brief
interventions administered both during and after the ED visit decreased post-ED suicidal
behavior.
JAMA Psychiatry. 2017;74(6):563-570. doi:10.1001/jamapsychiatry.2017.0678
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S uicidal behavior is a significant public health issue. In2015, there were 44 193 deaths by suicide in the UnitedStates.1 Suicide accounts for 1.2%of all deaths and is the
tenth leading cause of death in the United States.1 Attempted
suicide is an evenmore commonevent,withmore than 1mil-
lion people per year attempting suicide.1
Despite its significance, to our knowledge, few interven-
tiontrialshavetargetedand/or reducedsuicidalbehavior.Some
psychotherapies have been found to reduce rates of suicide
attempts,2-4 although there are concerns about publication
bias.5 Additionally, these interventions require substantial
training and are lengthy and costly to administer. Briefer, less
intensive interventions (eg, follow-up letters and reminder
postcards) have had mixed results.6 New interventions spe-
cifically developed to prevent suicidal behavior are clearly
needed.
Because emergency departments (EDs) treat many pa-
tients who are at risk for suicidal behavior, they are particu-
larly important locations for suicideprevention.More than4%
of all ED visits are attributable to psychiatric conditions,7 and
there are approximately 420000 visits every year for inten-
tional self-harm.8 These high-risk individuals are susceptible
to suicide attempts after their EDvisit.9Also, a significantpro-
portion of those who die by suicide received care in an ED in
the period prior to death.10-12
To address these ongoing public health issues, we con-
ducted amulticenter studyof adult EDpatientswho screened
positive for suicide attempts or ideation. In this article,we fo-
cus on the hypothesis that a multifaceted intervention deliv-
ered during and after the EDvisitwould decrease subsequent
suicidal behaviors compared with usual care.
Methods
Study Design and Settings
This article is part of the Emergency Department Safety
Assessment and Follow-up Evaluation (ED-SAFE) study
(clinicaltrials.gov identifier: NCT01150994). The ED-SAFE
studywasdesigned to examine the effect of universal screen-
ing andan interventionon individuals at risk for suicide in the
EDsetting.Descriptionof themethods13 andeffect14 of screen-
ing on risk detection have been reported previously. Partici-
pants with suicidal ideation or recent attempt were recruited
from 8 EDs across 7 states in the United States, ranging from
small community hospitals to large academic centers. To in-
creasegeneralizability,noparticipatingEDhadpsychiatric ser-
vices locatedwithinor adjacent to theED.TheED-SAFE study
consisted of 3 sequential phases at each site: (1) the treatment
as usual (TAU) phase, (2) the universal screening (screening)
phase, and (3) the universal screening plus intervention
(intervention) phase.
For all phases, following the index ED visit, enrolled par-
ticipants were observed for 1 year using telephone assess-
ments andmedical record reviews.Trainedblinded interview-
ersat a centralizedcall center conductedoutcomeassessments
at 6, 12, 24, 36, and 52weeks. If suicide riskwas detected, the
participant was immediately connected to the Boys Town
Suicide Prevention Hotline.15 Additionally, using a standard-
ized form, trained medical record abstractors at each site
conducted medical record reviews 6 and 12 months after
enrollment.
In the TAU phase, participants were treated according to
the usual and customary care at each site, serving as the con-
trol for the subsequent study phases. In the screening phase,
sites implementedclinicalprotocolswithuniversal suicide risk
screening (thePatient Safety Screener14) for all EDpatients. In
the intervention phase, in addition to universal screening, all
sites implemented a 3-component intervention: (1) a second-
ary suicide risk screeningdesigned forEDphysicians to evalu-
ate suicide risk following an initial positive screen, (2) thepro-
vision of a self-administered safety plan and information to
patients by nursing staff, and (3) a series of telephone calls to
theparticipant,with theoptional involvement of their signifi-
cantother (SO), for52weeks following the indexEDvisit.13The
structure and content of these callswere based on the Coping
LongTermwithActive SuicideProgram (CLASP) protocol,13,16
anadjunctive interventiondesigned to reduce suicide risk that
is composedof auniquecombinationof casemanagement, in-
dividual psychotherapy, and SO involvement. The clinician’s
primary role as theCLASPcontactwasmoreof a treatment ad-
visor than therapist. The CLASP-ED protocol consisted of up
to 7 brief (10- to 20-minute) telephone calls to the participant
andup to4 calls to anSO identified by theparticipant, if avail-
able (eTable 1 in the Supplement). The calls focused on iden-
tifying suicide risk factors, clarifying values and goals, safety
and future planning, facilitating treatment engagement/
adherence, and facilitating patient-SO problem-solving.Mul-
tiple attemptsweremade tocompleteeachscheduledcall, and
voicemails were left if the participant did not pick up. If a call
could not be completed, the advisor sent a personalized let-
ter expressingconcern for thepatient and inviting themtocall.
Calls followingCLASP-EDprotocolwerecentralizedatBut-
ler Hospital in Providence, Rhode Island, and were adminis-
tered by 10 advisors (6 PhD psychologists, 3 psychology fel-
lows, and 1masters-level counselor). All advisorswere trained
to criteria by thedevelopers ofCLASPand receivedweekly su-
pervision.
Institutional reviewboardsateachsiteapprovedthestudy.
All ED participants gave written consent. Because SOs in the
Key Points
Question Do emergency department (ED)–initiated interventions
reduce subsequent suicidal behavior among a sample of high-risk
ED patients?
Findings In this multicenter study of 1376 ED patients with recent
suicide attempts or ideation, compared with treatment as usual,
an intervention consisting of secondary suicide risk screening by
the ED physician, discharge resources, and post-ED telephone
calls focused on reducing suicide risk resulted in a 5% absolute
decrease in the proportion of patients subsequently attempting
suicide and a 30% decrease in the total number of suicide
attempts over a 52-week follow-up period.
Meaning For ED patients at risk for suicide, a multifaceted
intervention can reduce future suicidal behavior.
Research Original Investigation Suicide Prevention in an Emergency Department Population
564 JAMAPsychiatry June 2017 Volume 74, Number 6 (Reprinted) jamapsychiatry.com
© 2017 American Medical Association. All rights reserved.
Downloaded From:  by a University of Massachusetts User  on 11/09/2017
intervention phase were only contacted by telephone, these
participantsgaveverbalconsent.TheNational InstituteofMen-
tal Health Data and SafetyMonitoring Board conducted over-
all study oversight and monitoring.13
Participants
Adults presenting to one of the EDs with a suicide attempt or
ideationwithin theweek prior to the EDvisitwere eligible for
inclusion. Patients in the ED with any level of self-harm be-
havior or ideation were identified via real-time medical rec-
ord review and approached for eligibility screening. Patients
were enrolled if they confirmedeither a suicide attempt or ac-
tive suicidal ideationwithin thepastweekandagreed to study
requirements. Exclusion criteria included (1) beingmedically
or cognitivelyunable toparticipate in studyprocedures, (2) liv-
ing in a noncommunity setting, (3) being under state custody
or pending legal action, (4) being without permanent resi-
dence or reliable telephone service, and (5) having an insur-
mountable language barrier.
Outcomes
Outcomes were assessed by a combination of telephone in-
terviewsusingtheColumbiaSuicideSeverityRatingScale17and
medical record reviewover the52-week follow-upperiod.The
occurrence and timing of each outcome variable were as-
sessed using data collected from all possible sources. Re-
search team members reviewed data from all sources to rec-
oncile discrepancies and to eliminate overlap in identified
events.
Consistent with other suicide prevention trials, the pri-
mary outcome variable was suicide attempts (both fatal and
nonfatal)basedonColumbiaSuicideSeverityRatingScaledefi-
nitions.Weanalyzedboth theproportionofpatientswhomade
a suicide attempt and the total numberof suicide attempts oc-
curring during the 52-week follow-up period.
We also analyzed a broader suicide composite based on
the occurrence of any of 5 types of suicidal behavior:
death by suicide, suicide attempt, interrupted or aborted
attempts, and suicide preparatory acts.17 The time-to-event
for each participant was defined as the period from the
index ED visit to when the outcome occurred within
the 52-week follow-up period. Participants who did not
have an outcome were censored at time of withdrawal
(suicide attempt) or their last follow-up interview (suicide
composite).
Statistical Analysis
The sample-size calculationwas based on an assumed rate of
theprimaryoutcomeover the52-weekperiod in theTAUphase
of 20%.18,19 Thus, enrollment of 1440 patients has a power of
80% (at a 2-sided α level of .05) to detect an absolute risk re-
duction of 7 percentage points (or a relative risk reduction of
35%) in the interventionphase, allowing for an expected 20%
loss to follow-upover the 52-week follow-upperiod. Continu-
ousvariableswerereportedasmediansandinterquartile ranges
(IQRs) and categorical variables as proportions. Kruskal-
Wallis, χ2, andFisherexact testswereused toanalyzebetween-
phase baseline differences.
Analyses included all enrolled participants, with no ex-
clusions (intention-to-treat). To test for potential differences
in theproportionofpatientsmakinga suicideattempt,we first
calculatedabsolute risk reduction, relative risk reduction, and
number needed to treat (NNT). We then conducted survival
analyseswithKaplan-Meiermethodand log-rank test. To test
fordifferences in the total numberof suicideattempts, andbe-
causeouroutcomeswereoverlydispersed,weconductednega-
tive binomial regression.
These primary analyses were followed by several addi-
tional analyses. First, because our studywas a sequential de-
sign, we were aware of the potential for patient-level con-
founding across study phases. Therefore, consistentwith our
a priori data analytic plans, to control for potential differ-
ences between study phases, we created both Cox propor-
tional hazards andnegativebinomialmodels adjusting for po-
tential confounders that were selected based on clinical
knowledgeanddemonstratedpredictive relationshipwith sui-
cideoutcomesaswell asdummyvariables forparticipatingsite
(Table 1).Wedetectednoviolationof theproportionalityofhaz-
ards assumption using log cumulative hazards plots, Schoen-
feld residual plots, and time-dependent variables.20
We also conducted a pair of additional analyses to exam-
ine secular effects, including seasonality and site experience
with the intervention. In the first, we controlled for calendar
month to address possible seasonality effects. In another, we
adjusted for the effect of the relative length of time a site was
engaged in aparticular studyphase (ranging from−0.5 for the
first patient in a given phase to +0.5 for the last patient in a
phase) to control for effects of experience and comfort with
the study procedures. All analyses were performed with SAS
version 9.4 (SAS Institute) or STATA version 14.1 (StataCorp).
All P values were 2-tailed, with P < .05 considered statisti-
cally significant.
Results
Participant Characteristics
Of 1636 patients who met the study inclusion criteria, we
enrolled 1376 participants, including 497 in the TAU phase,
377 in the screening phase, and 502 in the intervention
phase (Figure 1). The median (IQR) age was 37 (26-47) years;
769 (55.9%) were female and 928 (67.4%) were non-
Hispanic white. A total of 987 (71.7%) of the sample had a
history of suicide attempts, and 459 (33.4%) had made an
attempt in the week prior to ED visit; 1202 (87.4%) had a
psychiatric disorder and 952 (69.2%) also had a coexisting
medical disorder. See Table 1 for other demographic and
clinical characteristics. Of 1376 enrolled participants, 1089
patients (79.1%) had at least 1 completed telephone inter-
view through 52 weeks; medical record reviews were com-
pleted on all participants.
Interventions
Secondary Suicide Screening
Medical record review indicated that 449 of 502 participants
(89.4%)had receiveda suicide risk assessment fromtheir phy-
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sician, but only 17 (3.9%) had documentation of the ED-SAFE
standardized secondary screening was used.
Safety Plan
Amongthoseparticipantswhocompletedthe initialCLASPcall,
114 (37.4%) reported having received a written safety plan in
the ED.
CLASP
Among 502 participants in the intervention phase, 305 par-
ticipants (60.8%) completed at least 1 CLASP telephone call.
Of those participants who completed at least 1 call, the me-
dian (IQR) number of completed calls was 6 (2-7). One hun-
dred participants (19.9%) had an SOwho completed at least 1
call. Significantotherscompletedamedian(IQR)of4 (3-4)calls.
Table 1. Characteristics of the Participants at Baseline by Study Phase
Characteristic
No. (%)
Phase 1: Treatment
as Usual (n = 497)
Phase 2: Universal
Screening (n = 377)
Phase 3: Universal
Screening Plus
Intervention (n = 502)
Demographic information
Age, median (IQR), ya 37 (26-46) 36 (28-48) 36 (24-47)
Femalea 278 (55.9) 210 (55.7) 281 (56.0)
Race/ethnicity
Non-Hispanic white 340 (68.4) 242 (64.2) 346 (68.9)
Non-Hispanic black 72 (14.5) 60 (15.9) 73 (14.5)
Hispanic 63 (12.7) 50 (13.3) 58 (11.6)
Other 22 (4.4) 25 (6.6) 25 (5.0)
Not married 407 (81.9) 295 (78.3) 415 (82.7)
Lives alonea,b 151 (30.4) 86 (22.8) 124 (24.7)
Served in the militarya 38 (7.7) 20 (5.3) 27 (5.4)
Education (≤high school) 251 (50.5) 192 (50.9) 260 (51.8)
Unemployed 304 (61.2) 247 (65.5) 289 (57.6)
Coexisting medical disordera 350 (70.4) 274 (72.7) 328 (65.3)
Heart disease 29 (5.8) 29 (7.7) 33 (6.6)
Cancer 10 (2.0) 12 (3.2) 19 (3.8)
HIV infection 10 (2.0) 7 (1.9) 8 (1.6)
Diabetes 58 (11.7) 40 (10.6) 60 (12.0)
Stroke 3 (0.6) 5 (1.3) 11 (2.2)
Chronic pain 130 (26.2) 261 (69.2) 307 (61.2)
Coexisting psychiatric disordera 432 (86.9) 334 (88.6) 436 (86.9)
Depression 409 (82.3) 315 (83.6) 406 (80.9)
Bipolar disorder 202 (40.6) 175 (46.4) 194 (38.6)
Anxiety 296 (59.6) 236 (62.6) 285 (56.8)
Schizophreniab 62 (12.5) 38 (10.1) 49 (9.8)
Lifetime suicide-related historya
Suicide attempt 351 (70.6) 268 (71.1) 368 (73.3)
Aborted attempt 296 (59.6) 241 (63.9) 301 (60.0)
Interrupted attemptb 272 (54.7) 238 (63.1) 285 (56.8)
Nonsuicidal self-injury 222 (44.7) 186 (49.3) 230 (45.8)
Severity of suicide ideation
(C-SSRS16), median (IQR)a
0 (0-5) 2 (0-5) 0 (0-5)
Health care use
ED visit for psychiatric problems
within the past 6 moa
168 (33.8) 125 (33.2) 150 (29.9)
Hospitalization for psychiatric
problems within past 6 moa
110 (22.1) 88 (23.3) 110 (21.9)
Suicide attempt within past wka 183 (36.8) 114 (30.2) 162 (32.3)
Substance use
Current alcohol misuse19a 181 (36.4) 117 (31.0) 173 (34.5)
Current drug usea 245 (49.3) 182 (48.3) 237 (47.2)
Psychological distress (GSI score20),
median (IQR)a
14 (9-18) 15 (10-19) 14 (8-18)
Quality of life (SF-6D score21),
median (IQR)a
17 (15-18) 16 (15-18) 17 (15-18)
Abbreviations: C-SSRS, Columbia
Suicide Severity Rating Scale; ED
emergency department; GSI, Global
Severity Index; HIV, human
immunodeficiency virus; IQR,
interquartile range; SF-6D, Short
Form 6DHealth Survey.
a Variable included in covariate
analyses.
bP < .05.
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Outcomes
Suicide Attempts
Overall, of 1376 participants, 288 (20.9%)made at least 1 sui-
cide attempt during the 12-month period. In the TAU phase,
114 of 497 participants (22.9%)made a suicide attempt, com-
paredwith81of377participants (21.5%) in thescreeningphase
and 92 of 502 participants (18.3%) in the intervention phase.
Five attempts were fatal, with fatalities observed in the TAU
phase (n = 2) and intervention phase (n = 3).
Ofparticipantswhoreportedanattempt, 164 (56.9%)made
1 attempt during the follow-up period, 53 (18.4%) made 2 at-
tempts, and67 (23.3%)made3ormore.Whencombined, there
were 548 total suicide attempts among participants, includ-
ing 224 in the TAU phase (0.45 per participant), 167 in the
screening phase (0.44 per participant), and 157 in the inter-
vention phase (0.31 per participant).
Primary Analyses
There were no meaningful differences in risk reduction be-
tweentheTAUandscreeningphases (Table2). Incontrast, com-
pared with the TAU phase, participants in the intervention
phase showed small butmeaningful reductions in suicide risk
(Table 2),with a relative risk reduction of 20%andNNTof 22.
Participants in the interventionphasehad30%fewer total sui-
cideattempts thanparticipants in theTAUor screeningphases
(Figure 2).
The survival curves for suicide attempts can be seen in
Figure3. Log-rank tests indicatednosignificantdifferencesbe-
tween theTAUandscreeningphases.ComparisonsofTAUand
Intervention were associated with a P value of .08. Negative
binomial regression analysis indicated that theparticipants in
the interventionphasehad significantly fewer total suicide at-
tempts than participants in the TAU phase (incidence rate ra-
Table 2. Risk Reduction
Suicidal Behavior Proportions
Absolute Risk Reduction
(95% CI)
Relative Risk
(95% CI)
Relative Risk Reduction
(95% CI) NNT
TAU vs SO
Suicide attempts TAU, 22.9% (114/497); SO,
21.5% (81/377)
0.15 (−0.04 to 0.07) 0.94 (0.73 to 1.20) −0.06 (−0.20 to 0.27) 69
Suicide composite TAU, 48.9% (243/497); SO,
49.6% (187/377)
0.07 (−0.06 to 0.07) 0.99 (0.89 to 1.17) −0.01 (−0.16 to 1.10) 141
TAU vs INT
Suicide attempts TAU, 22.9% (114/497); INT,
18.3% (92/502)
0.05 (0 to 0.10) 0.80 (0.63 to 1.02) 0.20 (0.02 to 0.38) 22
Suicide composite TAU, 48.9% (243/497); INT,
41.4% (208/502)
0.08 (0.01 to 0.14) 0.85 (0.74 to 0.97) 0.15 (0.03 to 0.26) 13
Abbreviations: INT, intervention; NNT, number needed to treat; SO, screening only; TAU, treatment as usual.
Figure 1. CONSORTDiagram
94 875 Patients assessed for eligibility 57 215 Patients assessed for eligibility 85 319 Patients assessed for eligibility
608 Patients met inclusion criteria 444 Patients met inclusion criteria 584 Patients met inclusion criteria
82 Excluded
63 Were unwilling or unable to
provide consent
5 Had no active suicidal ideation
or recent suicide attempt
2 Were medically or cognitively
unable to participate
2 Were previously enrolled
2 Were homeless
1 Had no reliable telephone
service
7 Were withdrawn
67 Excluded
45 Were unwilling or unable to
provide consent
8 Had no active suicidal ideation
or recent suicide attempt
1 Was medically or cognitively
unable to participate
1 Was in state custody
1 Was homeless
2 Were previously enrolled
1 Had other reasons
8 Were withdrawn
111 Excluded
74 Were unwilling or unable to
provide consent
15 Had no active suicidal ideation
or recent suicide attempt
2 Were medically or cognitively
unable to participate
1 Was in state custody
2 Were homeless
2 Had no reliable telephone
service
1 Was previously enrolled
4 Had other reasons
10 Were withdrawn
497 Patients enrolled to phase 1 and included in
intention-to-treat analysis
377 Patients enrolled to phase 2 and included in
intention-to-treat analysis
502 Patients enrolled to phase 3 and included in
intention-to-treat analysis
Phase 1: Treatment as usual
(August 2010-December 2011)
Phase 2: Universal screening
(September 2011-December 2012)
Phase 3: Universal screening plus intervention
(July 2012-November 2013)
Suicide Prevention in an Emergency Department Population Original Investigation Research
jamapsychiatry.com (Reprinted) JAMAPsychiatry June 2017 Volume 74, Number 6 567
© 2017 American Medical Association. All rights reserved.
Downloaded From:  by a University of Massachusetts User  on 11/09/2017
tio [IRR], 0.72; 95% CI, 0.52-1.00; P = .05) but no differences
betweentheTAUandscreeningphases (IRR, 1.00;95%CI,0.71-
1.41; P = .99). Therewere no significant site effects or site-by-
treatment interactions.
Secondary Analyses
Results fromthemultivariableCoxproportionalhazardsmodel
indicated that compared with participants in the TAU phase,
those in the screening phase had no significant difference in
theproportionofparticipantsmakingsuicideattempts (eTable
2 in the Supplement). However, compared with participants
in the TAU phase, participants in the intervention phase had
a significant reduction in risk of suicide attempts (hazard ra-
tio,0.73;95%CI,0.55-0.97;P = .03).Multivariablenegativebi-
nomial regression analysis also indicated that participants in
the intervention phase had fewer total suicide attempts than
those in the TAUphase (IRR, 0.75; 95%CI, 0.57-0.98;P = .04)
(eTable 3 in the Supplement).
There were no significant effects for either of the secular
trend analyses (both P > .05). Adding calendar month to the
Cox models did not yield significant seasonal effects nor
change the results of thesemodels. Similarly, therewasnoevi-
dence of trends within each phase (eTables 4 and 5 in the
Supplement).
Suicide Composite
Therewere 637 participants (46.3%)who had 1 ormore of the
behaviors comprising thesuicidecomposite. In theTAUphase,
243 participants (48.9%) had a suicide composite outcome,
compared with 187 (49.6%) in the screening phase and 208
(41.4%) in the intervention phase. Results of analyses of the
suicide composite largely mirrored those of the suicide at-
tempt variable.We foundno significant differences in the sui-
cide composite between TAU and screening phases. By con-
trast, survival (Z = −2.17; P = .03), multivariate Cox (hazard
ratio, 0.78; 95% CI, 0.64-0.94; P = .01), and negative bino-
mial (IRR, 0.78; 95% CI, 0.65-0.93; P = .01) analyses indi-
cated participants in the intervention phase had significantly
lower risk of overall suicidal behavior than those in the TAU
phase (eFigure and eTables 6 and 7 in the Supplement).
Discussion
To our knowledge, this study is the largest suicide interven-
tion trial ever conducted in theUnited States.More than 1300
participants with significant suicide risk from 8 EDs received
eitherTAU,universal screening, oruniversal screeningplus an
intervention consisting of an expanded suicide screening and
provision of a self-administered safety plan in the ED fol-
lowed by a telephone-based intervention delivered over 52
weeks. The results indicated that the provision of universal
screening,while successful in identifyingmoreparticipants,14
didnot significantly affect subsequent suicidal behavior com-
paredwith that experiencedbyparticipants in theTAUphase.
By contrast, those participants who received the interven-
tion had lower rates of suicide attempts and behaviors and
fewer total suicide attempts over a 52-week period. These re-
sults are consistentwithother studies demonstrating theutil-
ity of contact following discharge from EDs.21,22
The NNT to prevent future suicidal behavior ranged be-
tween 13 and 22. This level of risk reduction compares favor-
ably with other interventions to prevent major health issues,
including statins to prevent heart attack (NNT = 104),23 anti-
platelet therapy for acute ischemic stroke (NNT = 143),24
and vaccines to prevent influenza in elderly individuals
(NNT = 20).25
Becauseour interventionphasehad3components,wecan-
not identify their respective contributions to the observed re-
duction in suicidal behavior. Indeed, the implementation/
compliance with all components of the intervention was less
than optimal, with some participants not receiving portions
of the intervention, eitherdue to lackof implementation (stan-
dardized secondary screening and safetyplan) or patient non-
compliance (CLASP calls). In this report, we used conserva-
tive intent-to-treat analyses that included all participants
regardless of their compliance. However, it should be noted
Figure 3. Proportion of ParticipantsWhoDid NotMake a Suicide
Attempt Over Time
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Figure 2. Total Suicide Attempts per Participant by Phase
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that all participants in the intervention phase received sub-
stantial outreach via telephone messages and letters from
CLASP advisors. It is possible that these nonspecific expres-
sionsofconcernandcaringmayhavehadabeneficialeffect26,27
in the absence of completed telephone calls.
Although the procedures of this study did improve sui-
cide risk detection rates,14we foundno evidence that univer-
sal screeningalone improvedoutcomesafter theEDvisit.How-
ever, the patients recruited for inclusion in the longitudinal
follow-upof this studyhadall been identified clinically ashav-
ing suicide risk and represent only a small subset of actual
screen-positive patients among the entire ED population. Po-
tential advantages of universal screening may be seen with
larger, population-based studies.
Wealsonote that for research andethical reasons, partici-
pants in all phases, including the TAUphase, received assess-
ment calls to assess suicide risk, followed by potential refer-
ral toasuicidehotline. It ispossible that thesesafetyprocedures
decreased subsequent suicidal behavior across all phases.We
believe that this insurmountable challenge of suicide preven-
tion researchmay have reduced the potential differences be-
tween the TAU and intervention phases.
Limitations
Our study has several limitations. First, we used a sequential
design instead of a randomized clinical trial. While our de-
sign allowed investigationof system-based interventions that
would have been impossible with a traditional randomized
clinical trial, it is possible that time or other nonstudy sys-
temic changes may have produced differences in participant
samplesorotherunknownfactorsacrossphases.Whilewecon-
trolledstatistically forpotentialdifferences insamplesandtime
by using multiple covariates and analyses of seasonality and
experience with study procedures (eTables 1, 2, and 3 in the
Supplement), other factors may have influenced outcomes.
However, there were no major changes in treatment of sui-
cidal individuals during the timeof our study, both at the sites
and nationwide, and national suicide rates remained con-
stant or even increased over the study period.1 Second, con-
sistentwithvirtually everyother suicide intervention trial,we
did not have sufficient power to detect differences in actual
deathsbysuicide.Whilesuicideattemptsarean importantpub-
lic health issue,28 much larger trials will be necessary to ad-
equately study the effect of interventions on suicide deaths.
Conclusions
In thismulticenter study of EDpatientswith elevated suicide
risk, we found that amultifaceted intervention (composed of
brief in-ED interventions and a series of telephone calls after
EDdischarge)producedasmall butmeaningful reduction (5%)
in the proportion of participants who attempted suicide over
the 12-month observationperiod.Moreover, the intervention
led to a 30% reduction in the overall number of suicide
attempts.
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